89bio, Inc. Made Headway

Tue, Sep 13, 2022 at 07:19 PM
89bio, Inc. Made Headway

89bio, Inc. (ETNB:NASDAQ) jumped higher at $7, a gain of 40%. On Tue, Sep 13, 2022, ETNB:NASDAQ touched a New 2-Week High of $7. The stock appeared on our News Catalysts scanner on Wed, Sep 07, 2022 at 09:08 AM in the 'MISCELLANEOUS' category. From Tue, Aug 30, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days

About 89bio, Inc. (ETNB:NASDAQ)

89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.